TABLE 2

Summary of the regulation of mouse biotransformation enzymes and Oatps in liver after treatment with prototypical activators of transcription factor signaling pathways




AhR Ligands

CAR Activators

PXR Ligands

PPARα Ligands

Nrf2 Activators
Cyp1A1 +(3/3) 0 0 0 0
Cyp2B10 0 +(3/3) 0 0 0
Cyp3A11 +(2/3) +(3/3) +(3/3) 0 +(3/3)
Cyp4A14 0 0 0 +(3/3) 0
Nqo1 +(3/3) +(2/3) 0 0 +(3/3)
Oatp1a1 -(2/3) -(3/3) -(3/3) -(3/3) -(2/3)
Oatp1a4 0 0 +(2/3) 0 0
Oatp1a5 0 -(2/3) -(2/3) 0 0
Oatp1a6 0 0 0 -(2/3) 0
Oatp1b2 0 0 0 0 0
Oatp1c1 0 0 0 0 0
Oatp2a1 0 0 -(3/3) -(3/3) 0
Oatp2b1 +(2/3) 0 -(2/3) -(3/3) +(2/3)
Oatp3a1 +(3/3) 0 -(3/3) 0 0
Oatp4a1
0
0
0
0
0
  • + indicates up-regulation of mouse Oatp mRNA expression; — indicates down-regulation of mouse Oatp mRNA expression; 0 indicates no effects on mouse Oatp mRNA expression; 2/3 indicates 2 ligands have effects of the 3 ligands in a transcription pathway.